XML 62 R52.htm IDEA: XBRL DOCUMENT v3.25.4
Acquisitions - Additional Information (Detail) - USD ($)
$ in Thousands
 12 Months Ended
Mar. 04, 2025
Dec. 02, 2024
Oct. 02, 2023
Apr. 17, 2023
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Business Combination [Line Items]              
Provisional goodwill         $ 1,114,408 $ 1,030,995 $ 987,120
908 Devices Inc. Bioprocessing Analytics Portfolio              
Business Combination [Line Items]              
Business combination, consideration transferred $ 70,300            
Transaction costs $ 12,500            
Provisional goodwill         50,177    
908 Devices Inc. Bioprocessing Analytics Portfolio | Developed Technology              
Business Combination [Line Items]              
Fair value of acquired finite lived intangible assets         6,910    
908 Devices Inc. Bioprocessing Analytics Portfolio | U.S Entity              
Business Combination [Line Items]              
Goodwill allocated deductible for income tax purposes         39,600    
908 Devices Inc. Bioprocessing Analytics Portfolio | Germany Entity              
Business Combination [Line Items]              
Goodwill allocated deductible for income tax purposes         10,600    
Tantti Laboratory Inc.              
Business Combination [Line Items]              
Cash consideration   $ 55,400          
Value of common stock issued   75,100          
Business combination contingent consideration   $ 19,700          
Weighted Average Useful Life (in years)           9 years  
Transaction costs         4,700    
Acquisition related costs         3,100    
Provisional goodwill         46,943 $ 46,900  
Tantti Laboratory Inc. | Developed Technology              
Business Combination [Line Items]              
Fair value of acquired finite lived intangible assets         28,910 $ 28,900  
Metenova Holding AB              
Business Combination [Line Items]              
Cash consideration     $ 164,500        
Value of common stock issued     $ 172,600        
Shares issued for business acquisition     52,299        
Transaction costs         6,500    
Provisional goodwill         115,722   115,700
Metenova Holding AB | Common Stock              
Business Combination [Line Items]              
Value of common stock issued     $ 8,100        
Metenova Holding AB | Developed Technology              
Business Combination [Line Items]              
Fair value of acquired finite lived intangible assets         $ 44,377    
Weighted Average Useful Life (in years)         15 years    
FlexBiosys, Inc.              
Business Combination [Line Items]              
Cash consideration       $ 29,000      
Value of common stock issued       41,000      
Business combination contingent consideration       $ 6,600      
Shares issued for business acquisition       31,415      
Transaction costs         $ 900    
Provisional goodwill         14,321   $ 14,300
Business combination date of acquistion       Apr. 17, 2023      
FlexBiosys, Inc. | Common Stock              
Business Combination [Line Items]              
Value of common stock issued       $ 5,400      
FlexBiosys, Inc. | Developed Technology              
Business Combination [Line Items]              
Fair value of acquired finite lived intangible assets         $ 9,860    
Weighted Average Useful Life (in years)         16 years